2020 annual financial data
Amphastar Pharmaceuticals 2020 Operating margin
Direct answer
Operating margin was 3.13%.
Operating income was 10,954,000 USD and net income was 1,403,000 USD.
Operating cash flow was 57,266,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 349,846,000 USD
- Operating income
- 10,954,000 USD
- Net income
- 1,403,000 USD
- Operating cash flow
- 57,266,000 USD